About me
Dr. Tee Khim Boon is a regulatory expert specializing in GCP and BE inspections. She contributes to Malaysia’s NPRA, ensuring data integrity across borders. Between 2014 and 2023, she led oversight missions in India, Taiwan, Thailand, Indonesia, and Romania . Over the past three years, she has modernized clinical trial regulations through regulatory impact analyses and stakeholder engagements. She served as editor for seven local guidelines, including the Malaysian Guideline for GCP. Her work includes evaluate and review clinical trials authorization in Malaysia and balancing academic contributions with field-based regulatory enforcement to meet global pharmaceutical standards.
